HER2-positive breast cancer, once associated with poor outcomes, now sees improved prognosis due to targeted therapies like Herceptin. Combination therapies ... the utilization of neoadjuvant therapy.

Life is funny sometimes. I passed by a car workshop the other day and saw my neighbour’s car — the same car that just missed ...

My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Oracle Corporation third quarter fiscal year '25 earnings conference call. All ...

U.S. Senator Cindy Hyde-Smith (R-Miss.), chair of the Senate Pro-Life Caucus, this week jumpstarted her goal to end federal ...

Prince Charles has become embroiled in the row over the use of alternative medicine after he gave a speech embracing the practice. Speaking at the World Health Organisation, the Prince, a long ...

To do this, the Commercial Medicines Directorate ... which were versions of the cancer drugs MabThera (rituximab) and Herceptin (trastuzumab). This time around incentives were put in place under ...

Other medical research groups are also lobbying Congress this week to do something about the proposed ... “Cutting these vital research funds does a great disservice to our warfighters and ...

It is hoped that by coupling trastuzumab (Herceptin; Genentech/Roche ... ADCs (which link an antibody to a cytotoxic agent; this does not include antibodies conjugated to radioisotopes ...

In the case of Yervoy, the manufacturer must repay 100% of treatment costs for patients who do not receive the third ... approach to the reimbursement of Herceptin® (trastuzumab, Roche) in ...